When it comes to invention rights (patents) it is often difficult to determine who is a victim and who is merely promoting its agenda. Life360,
When it comes to invention rights (patents) it is often difficult to determine who is a victim and who is merely promoting its agenda. Life360,
More than half of Google and Microsoft’s 2014 US patent grants were in methods-related classes. IBM and Apple also were active filers in these areas.
Executives of top patent holders will participate in “NPE 2015: The Business of Responsible Licensing” to be held in NYC’s financial district on March 12.
Size helped in 2014 when it came to public IP licensing company stock performance, but it did not assure success. As a group, the twelve
Opportunities still exist to monetize patents for those willing to do their homework and adjust expectations, veteran patent licensing executive Bob Bramson, a WiLAN director,
VirnetX announced that it has settled a patent infringement suit with Microsoft for $23 million sending its shares up 20%. VirnetX (NYSE: VHC), whose stock had
More than one-third of the IP CloseUp® 30 public patent licensing companies (or PIPCOs) are currently selling for less than or about $1 per share —
The stock market continues to defy expectations. Even more surprising, a few PIPCOs have dramatically outperformed it. Smaller cap patent stocks have not fared so
The rights to an expensive drug treatment owned by the Cystic Fibrosis Foundation has helped it to reap a financial windfall but is not without
Cisco deal shows reports of patent licensing’s death have been greatly exaggerated. Patent licensing may no longer be what it once was in areas
As businesses adjust to new judicial and legislative requirements public patent licensing companies will have to work harder and think smarter to compete against the
With three recent Markman hearings and more than $100M in cash UPIP trading currently at $1.46 could be a good buy for those with patience